Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cardiff Oncology
Biotech
ASCO: Cardiff posts updated colorectal data before pivotal push
Cardiff shared updated phase 2 colorectal cancer data, revealing that the study drug has yet to reach the median progression-free survival.
Nick Paul Taylor
Jun 2, 2026 9:06am
Former TreeFrog CEO leaps to Orano Med—Chutes & Ladders
Apr 10, 2026 8:30am
Cardiff Oncology churns C-suite—Chutes & Ladders
Jan 30, 2026 8:30am
Cardiff posts updated colorectal cancer data, sinking stock
Jul 30, 2025 7:25am
BMS banks on Wall Street vet for strategy— Chutes & Ladders
Jun 20, 2025 8:30am
High dose of Cardiff's KRAS drug shows 64% ORR, sending stock up
Dec 10, 2024 4:05pm
